TwinBeech Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-182,147
| Closed | -$21M | – | 826 |
|
|
2024
Q3 | $21M | Buy |
182,147
+130,947
| +256% | +$15.1M | 0.4% | 66 |
|
|
2024
Q2 | $7.05M | Buy |
51,200
+24,348
| +91% | +$3.35M | 0.14% | 179 |
|
|
2024
Q1 | $3.7M | Buy |
+26,852
| New | +$3.7M | 0.08% | 254 |
|
|
2023
Q4 | – | Sell |
-81,340
| Closed | -$9.15M | – | 817 |
|
|
2023
Q3 | $9.15M | Buy |
81,340
+76,406
| +1,549% | +$8.6M | 0.18% | 159 |
|
|
2023
Q2 | $465K | Sell |
4,934
-15,905
| -76% | -$1.5M | 0.01% | 513 |
|
|
2023
Q1 | $2.11M | Buy |
20,839
+12,229
| +142% | +$1.24M | 0.04% | 369 |
|
|
2022
Q4 | $1.03M | Buy |
+8,610
| New | +$1.03M | 0.02% | 511 |
|
|
2021
Q4 | – | Sell |
-11,544
| Closed | -$1.11M | – | 729 |
|
|
2021
Q3 | $1.11M | Sell |
11,544
-674
| -6% | -$64.6K | 0.08% | 312 |
|
|
2021
Q2 | $1.19M | Buy |
+12,218
| New | +$1.19M | 0.14% | 195 |
|
|
2020
Q1 | – | Sell |
-9,526
| Closed | -$1.02M | – | 413 |
|
|
2019
Q4 | $1.02M | Buy |
+9,526
| New | +$1.02M | 0.3% | 113 |
|